Login Register Cart 0
Generic placeholder image

Recent Patents on Anti-Cancer Drug Discovery

Editor-in-Chief

ISSN (Print): 1574-8928
ISSN (Online): 2212-3970

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer

Author(s): Zefeng Wang, Qianfei Cui, Ling Shi, Meiling Zhang, Peng Song*, Dongzhu Duan* and Wenjing Guo*

Volume 17, Issue 3, 2022

Published on: 01 March, 2022

Page: [297 - 311] Pages: 15

DOI: 10.2174/1574892817666211224142100

Price: $65

Abstract

Background: Shikonin (SKN), a naturally occurring naphthoquinone, is a major active chemical component isolated from Lithospermum erythrorhizon Sieb Zucc, Arnebia euchroma (Royle) Johnst, or Arnebia guttata Bunge, and commonly used to treat viral infection, inflammation, and cancer. However, its underlying mechanism has not been elucidated.

Objective: This study aims to explore the antitumor mechanism of SKN in colorectal cancer (CRC) through network pharmacology and cell experiments.

Methods: SymMap database and Genecards were used to predict the potential targets of SKN and CRC, while the cotargets were obtained by Venn diagram. The cotargets were imported into the website of String and DAVID, constructing the protein-protein interaction (PPI) network, performing Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, the Compound-Target-Pathway (C-T-P) network was generated by connecting potential pathways with the corresponding targets.

Results: According to the results of network pharmacological analysis, the cell experiments were used to verify the key signal pathway. The most relevant target of SKN for the treatment of CRC was PI3K/Akt signaling pathway. SKN inhibited CRC cells (HT29 and HCT116) proliferation, migration, and invasion, and promoted cell apoptosis by targeting IL6 and inhibiting the IL6R/PI3K/Akt signaling pathway. SKN promotes apoptosis and suppresses CRC cells’ (HT29 and HCT116) activity through the PI3K-Akt signaling pathway.

Conclusion: This research not only provided a theoretical and experimental basis for more in- -depth studies but also offered an efficient method for the rational utilization of a series of Traditional Chinese medicines as anti-CRC drugs.

Keywords: Shikonin, colorectal cancer, network pharmacology, target analysis, molecular docking, cell experiments, signaling pathway.

« Previous Next »
[1]
Hu C, Cao Y, Li P, et al. Oleanolic acid induces autophagy and apoptosis via the AMPK-mTOR signaling pathway in colon cancer. J Oncol 2021; 2021: 8281718.
[http://dx.doi.org/10.1155/2021/8281718] [PMID: 34326874]
[2]
Ren J, Feng J, Song W, Wang C, Ge Y, Fu T. Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer. Clin Exp Med 2020; 20(4): 535-44.
[http://dx.doi.org/10.1007/s10238-020-00652-1] [PMID: 32772211]
[3]
Li SY, Shang J, Mao XM, et al. Diosgenin exerts anti-tumor effects through inactivation of cAMP/PKA/CREB signaling pathway in colorectal cancer. Eur J Pharmacol 2021; 908: 174370.
[http://dx.doi.org/10.1016/j.ejphar.2021.174370] [PMID: 34324855]
[4]
Jeong S, Chessin D, Schrag D, Riedel E, Wong W, Guillem J. Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2005; 97(22): 1705-6.
[5]
Wang S, Gao J, Li Q, et al. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology. J Ethnopharmacol 2020; 262: 113189.
[http://dx.doi.org/10.1016/j.jep.2020.113189] [PMID: 32736044]
[6]
Liu Z, Lu L, Zheng H, et al. Application of shikonin in preparing drug for treating lung cancer. CN. 107137384A, 2017.
[7]
Zhang B, Chen N, Zheng Q, Chen H, Wang X. Application of Shikonin in medicine for treating acute leukemia. CN 103720679A, 2012.
[8]
Liu Z, Li H, Ma W, Pan S. Network pharmacology to investigate the pharmacological mechanisms of muscone in Xingnaojing injections for the treatment of severe traumatic brain injury. PeerJ 2021; 9: e11696.
[http://dx.doi.org/10.7717/peerj.11696] [PMID: 34322321]
[9]
Yang LN, Wu ZL, Yang ZJ, Li SG, Ouyang CS. Exploring mechanism of key chinese herbal medicine on breast cancer by data mining and network pharmacology methods. Chin J Integr Med 2020; 1-8.
[http://dx.doi.org/10.1007/s11655-020-3422-y] [PMID: 32572780]
[10]
Deng J, Ma Y, He Y, et al. Isatis indigotica network pharmacology-based investigation to the pharmacodynamic material basis and mechanisms of the anti-inflammatory and anti-viral effect of. Drug Des Devel Ther 2021; 15: 3193-206.
[http://dx.doi.org/10.2147/DDDT.S316701] [PMID: 34321868]
[11]
Pan Q, Wu K, Tan J, Li Y, Liang X, Su M. Anti-neoplastic characteristics and potential targets of calycosin against bisphenol A-related osteosarcoma: bioinformatics analysis. Bioengineered 2021; 12(1): 4278-88.
[http://dx.doi.org/10.1080/21655979.2021.1956401] [PMID: 34311656]
[12]
Cheng H, Weng WJ, Xie H. Au-Pt@Biomass porous carbon composite modified electrode for sensitive electrochemical detection of baicalein. Microchem J 2020; 154: 104602.
[http://dx.doi.org/10.1016/j.microc.2020.104602]
[13]
P LP. Chinese herbal preparation for treating breast cancer and capable of relieving side effect of endocrinotherapy of breast cancer. CN 104689260A(B), 2015.
[14]
Wang HL. Traditional Chinese medicine composition for treating psoriasis. CN 104689132A, 2015.
[15]
Yao Y, Zhong J, Lu Z, et al. Nitrogen-doped carbon frameworks decorated with palladium nanoparticles for simultaneous electrochemical voltammetric determination of uric acid and dopamine in the presence of ascorbic acid. Mikrochim Acta 2019; 186(12): 795.
[http://dx.doi.org/10.1007/s00604-019-3907-6] [PMID: 31734752]
[16]
Liu C, He L, Wang J, et al. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. J Ethnopharmacol 2020; 260: 113039.
[http://dx.doi.org/10.1016/j.jep.2020.113039] [PMID: 32497675]
[17]
Guo C, He J, Song X, et al. Pharmacological properties and derivatives of shikonin-A review in recent years. Pharmacol Res 2019; 149: 104463.
[http://dx.doi.org/10.1016/j.phrs.2019.104463] [PMID: 31553936]
[18]
Lee YS, Lee DY, Kim YB, et al. The mechanism underlying the antibacterial activity of shikonin against methicillin-resistant staphylococcus aureus. Evid Based Complement Alternat Med 2015; 2015: 520578.
[http://dx.doi.org/10.1155/2015/520578] [PMID: 26265924]
[19]
Kumar A, Shashni S, Kumar P, Pant D, Singh A, Verma RK. Phytochemical constituents, distributions and traditional usages of Arnebia euchroma: A review. J Ethnopharmacol 2021; 271: 113896.
[http://dx.doi.org/10.1016/j.jep.2021.113896] [PMID: 33524510]
[20]
Todorovic Z, Milovanovic J, Arsenijevic D, et al. Onsoma visianii shikonin derivatives from decrease expression of phosphorylated STAT3 in leukemia cells and cxert antitumor activity. Nutrients 2021; 13(4): 1147.
[http://dx.doi.org/10.3390/nu13041147] [PMID: 33807148]
[21]
Chandimali N, Sun HN, Kong LZ, et al. Shikonin-induced apoptosis of colon cancer cells Is reduced by peroxiredoxin V expression. Anticancer Res 2019; 39(11): 6115-23.
[http://dx.doi.org/10.21873/anticanres.13819] [PMID: 31704839]
[22]
Liu TH, Tu WQ, Tao WC, Liang QE, Xiao Y, Chen LG. Verification of resveratrol inhibits intestinal aging by downregulating ATF4/Chop/Bcl-2/Bax signaling pathway: based on network pharmacology and animal experiment. Front Pharmacol 2020; 11: 1064.
[http://dx.doi.org/10.3389/fphar.2020.01064] [PMID: 32754039]
[23]
Qin T, Wu L, Hua Q, Song Z, Pan Y, Liu T. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation. J Ethnopharmacol 2020; 246: 112128.
[http://dx.doi.org/10.1016/j.jep.2019.112128] [PMID: 31386888]
[24]
Dai S, Zhang G, Zhao F, Shu Q. Study on the molecular mechanism of the herbal couple sparganii rhizoma-curcumae rhizoma in the treatment of lung cancer based on network pharmacology. Evid Based Complement Alternat Med 2021; 2021: 6664489.
[http://dx.doi.org/10.1155/2021/6664489] [PMID: 34239587]
[25]
Zaslavsky L, Cheng T, Gindulyte A, et al. Discovering and summarizing relationships between chemicals, genes, proteins, and diseases in pubChem. Front Res Metr Anal 2021; 6: 689059.
[http://dx.doi.org/10.3389/frma.2021.689059] [PMID: 34322655]
[26]
Wang ZF, Hu YQ, Wu QG, Zhang R. Virtual screening of potential anti-fatigue mechanism of polygonati rhizoma based on network pharmacology. Comb Chem High Throughput Screen 2019; 22(9): 612-24.
[http://dx.doi.org/10.2174/1386207322666191106110615] [PMID: 31694519]
[27]
Duan L, Jin , An X, et al. Rhizoma coptidis the potential effect of on polycystic ovary syndrome based on network pharmacology and molecular docking. Evid Based Complement Alternat Med 2021; 2021: 5577610.
[http://dx.doi.org/10.1155/2021/5577610] [PMID: 34306142]
[28]
Xu HH, Li SM, Xu R, Fang L, Xu H, Tong PJ. Predication of the underlying mechanism of Bushenhuoxue formula acting on knee osteoarthritis via network pharmacology-based analyses combined with experimental validation. J Ethnopharmacol 2020; 263: 113217.
[http://dx.doi.org/10.1016/j.jep.2020.113217] [PMID: 32763417]
[29]
Shi L, Wu QG, Zhang JC, Yang GM, Liu W, Wang ZF. Mechanism of shuang-huang-lian oral liquid for treatment of mycoplasmal pneumonia in children on network pharmacology. Comb Chem High Throughput Screen 2020; 23(9): 955-71.
[http://dx.doi.org/10.2174/1386207323666200514073428] [PMID: 32407262]
[30]
Xue S, Ma M, Bei S, et al. Identification and validation of the immune regulator CXCR4 as a novel promising target for gastric cancer. Front Immunol 2021; 12: 702615.
[http://dx.doi.org/10.3389/fimmu.2021.702615] [PMID: 34322132]
[31]
Cui Q, Ma YH, Yu HY, et al. Systematic analysis of the mechanism of hydroxysafflor yellow A for treating ischemic stroke based on network pharmacology technology. Eur J Pharmacol 2021; 908: 174360.
[http://dx.doi.org/10.1016/j.ejphar.2021.174360] [PMID: 34302817]
[32]
Huang S, Zhang Z, Li W, et al. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Zuojinwan for treating colorectal cancer. Drug Des Devel Ther 2020; 14: 2725-40.
[http://dx.doi.org/10.2147/DDDT.S250991] [PMID: 32764874]
[33]
Liang XZ, Li R, Xu B, et al. Systematic evaluation of the mechanisms of zoledronic acid based on network pharmacology. Comput Biol Chem 2019; 83: 107097.
[http://dx.doi.org/10.1016/j.compbiolchem.2019.107097] [PMID: 31446368]
[34]
Zhuang Z, Wen J, Zhang L, et al. Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection? Eur J Integr Med 2020; 37: 101139.
[http://dx.doi.org/10.1016/j.eujim.2020.101139] [PMID: 32501408]
[35]
Zeng Q, Li L, Siu W, et al. A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer’s disease. Biomed Pharmacother 2019; 120: 109370.
[http://dx.doi.org/10.1016/j.biopha.2019.109370] [PMID: 31563815]
[36]
Rojo Arias JE, Jászai J. Gene expression profile of the murine ischemic retina and its response to Aflibercept (VEGF-Trap). Sci Rep 2021; 11(1): 15313.
[http://dx.doi.org/10.1038/s41598-021-94500-1] [PMID: 34321516]
[37]
Song X, Zhang Y, Dai E, Du H, Wang L. Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis. Int Immunopharmacol 2019; 74: 105725.
[http://dx.doi.org/10.1016/j.intimp.2019.105725] [PMID: 31276975]
[38]
Shi L, Chen W, Zhang Z, Chen J, Xue M. N1-methyladenosine profiling of long non-coding RNA in colorectal cancer. IUBMB Life 2021; 73(10): 1235-43.
[http://dx.doi.org/10.1002/iub.2534] [PMID: 34314547]
[39]
Yu G, Luo Z, Zhou Y, et al. Uncovering the pharmacological mechanism of Carthamus tinctorius L. on cardiovascular disease by a systems pharmacology approach. Biomed Pharmacother 2019; 117: 109094.
[http://dx.doi.org/10.1016/j.biopha.2019.109094] [PMID: 31203131]
[40]
Li CX, He QY, Liu J, et al. Predictive analysis of quality markers of Coptidis Rhizoma based on network pharmacology and multivariate statistical analysis. Zhongguo Zhongyao Zazhi 2021; 46(11): 2718-27.
[PMID: 34296568]
[41]
Zhang Y, Wu Y, Fu Y, et al. Anti-Alzheimer’s disease molecular mechanism of acori tatarinowii rhizoma based on network pharmacology. Med Sci Monit Basic Res 2020; 26: e924203.
[PMID: 32475979]
[42]
Zhang Y, Li X, Guo C, Dong J, Liao L. Mechanisms of spica prunellae against thyroid-associated ophthalmopathy based on network pharmacology and molecular docking. BMC Complement Med Ther 2020; 20(1): 229.
[http://dx.doi.org/10.1186/s12906-020-03022-2] [PMID: 32689994]
[43]
Blanchetot C, De Jonge N, Desmyter A, et al. Structural mimicry of receptor interaction by antagonistic interleukin-6 (IL-6) antibodies. J Biol Chem 2016; 291(26): 13846-54.
[http://dx.doi.org/10.1074/jbc.M115.695528] [PMID: 27129274]
[44]
Ukwenya V, Adelakun S, Elekofehinti O. Anacardium occidentaleExploring the antidiabetic potential of compounds isolated from using computational aproach: ligand-based virtual screening. in silico Pharmacol 2021; 9(1): 25.
[http://dx.doi.org/10.1007/s40203-021-00084-z] [PMID: 33868895]
[45]
Zou T, Huang Y, Hu Y, et al. Study on the anti-tumor mechanism and target of triptolide based on network pharmacology and molecular docking. Recent Pat Anti-Cancer Drug Discov 2021; 16(3)
[46]
Kikiowo B, Adewale J, T OI. Induced fit docking and automated QSAR studies reveal the ER-α inhibitory activity of cannabis sativa in breast cancer. Recent Pat Anti-Cancer Drug Discov 2021; 16: 1-11.
[http://dx.doi.org/10.2174/1574892816666210201115359]
[47]
Song P, Chen P, Wang D, et al. Realgar transforming solution displays anticancer potential against human hepatocellular carcinoma HepG2 cells by inducing ROS. Int J Oncol 2017; 50(2): 660-70.
[http://dx.doi.org/10.3892/ijo.2016.3831] [PMID: 28035418]
[48]
Sheng X, Zhu P, Zhao Y, et al. Effect of PI3K/AKT/mTOR signaling pathway on regulating and controlling the anti-invasion and metastasis of hepatoma cells by bufalin. Recent Pat Anti-Cancer Drug Discov 2021; 16(1): 54-65.
[http://dx.doi.org/10.2174/1574892816666210201120324] [PMID: 33530915]
[49]
Li F, Li L, Zhong Y, et al. Relationship between LTR methylation and gag expression of HIV-1 in human spermatozoa and sperm-derived embryos. PLoS One 2013; 8(1): e54801.
[http://dx.doi.org/10.1371/journal.pone.0054801] [PMID: 23382972]
[50]
Wang T, Zhang Y, Guo Y, et al. RNA-sequence reveals differentially expressed genes affecting the crested trait of Wumeng crested chicken. Poult Sci 2021; 100(9): 101357.
[http://dx.doi.org/10.1016/j.psj.2021.101357] [PMID: 34329989]
[51]
Kim M, Moon J, Cho Y. SGLT2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body-induced NRF2 activation. Diabetes Obes Metab 2021.
[http://dx.doi.org/10.1111/dom.14503]
[52]
Gao F, Dong W, Liu P, et al. Molecular changes in miRNA in irradiated rat kidneys: role of miR-34a and its vascular targets in the notch pathway. Radiat Res 2021.
[http://dx.doi.org/10.1667/RADE-20-00078.1] [PMID: 34330145]
[53]
Lin L, Gu X, Chen L, et al. Study on the alleviation of Fengshi Gutong capsule on rheumatoid arthritis through integrating network pharmacology and experimental exploration. J Ethnopharmacol 2021; 280: 114471.
[http://dx.doi.org/10.1016/j.jep.2021.114471] [PMID: 34329717]
[54]
Li MY, Li MX, Xu N, et al. Effects of huangqin decoction on ulcerative colitis by targeting estrogen receptor alpha and ameliorating endothelial dysfunction based on system pharmacology. j ethnopharmacol 2021; 271: 113886.
[http://dx.doi.org/10.1016/j.jep.2021.113886] [PMID: 33524513]
[55]
Jin J, Zhou M, Wang X, et al. Triptolidenol, isolated from Tripterygium wilfordii, disrupted NF-κB/COX-2 pathway by targeting ATP-binding sites of IKKβ in clear cell renal cell carcinoma. Fitoterapia 2021; 148: 104779.
[http://dx.doi.org/10.1016/j.fitote.2020.104779] [PMID: 33242535]
[56]
Gao K, Song YP, Du X, Chen H, Zhao LT. Exploring multiple mechanisms of Qingjie Fanggan prescription for prevention and treatment of influenza based on systems pharmacology. Comput Biol Chem 2020; 88: 107307.
[http://dx.doi.org/10.1016/j.compbiolchem.2020.107307] [PMID: 32622176]
[57]
Zhang J, Zhao J, Ma Y, et al. Investigation of the multi-target mechanism of guanxin-shutong capsule in cerebrovascular diseases: A systems pharmacology and experimental assessment. Front Pharmacol 2021; 12: 650770.
[http://dx.doi.org/10.3389/fphar.2021.650770] [PMID: 34054530]
[58]
Saadat N, Mayo CD, Lacey C, Gawryluk JR. Functional connectivity pre-post exercise intervention in individuals with relapsing-remitting multiple sclerosis. Neuroreport 2021; 32(13): 1100-5.
[http://dx.doi.org/10.1097/WNR.0000000000001702] [PMID: 34284447]
[59]
Huang L, Wu H, Yan H, et al. Syphilis testing as a proxy marker for a subgroup of men who have sex with men with a central role in HIV-1 transmission in guangzhou, China. Front Med (Lausanne) 2021; 8: 662689.
[http://dx.doi.org/10.3389/fmed.2021.662689] [PMID: 34307399]
[60]
Laamari Y, Oubella A, Bimoussa A, et al. Design, Hemiysnthesis, crystal structure and anticancer activity of 1, 2, 3-triazoles derivatives of totarol. Bioorg Chem 2021; 115: 105165.
[http://dx.doi.org/10.1016/j.bioorg.2021.105165] [PMID: 34298240]
[61]
Qiu CZ, Wang C, Huang ZX, Zhu SZ, Wu YY, Qiu JL. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer. World J Gastroenterol 2006; 12(13): 2011-5.
[http://dx.doi.org/10.3748/wjg.v12.i13.2011] [PMID: 16610049]
[62]
Pandey T, Shukla A, Trivedi M, Khan F, Pandey R. Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway. Bioorg Chem 2021; 108: 104655.
[http://dx.doi.org/10.1016/j.bioorg.2021.104655] [PMID: 33548732]
[63]
Li C, Yang P, Liu B, et al. Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K/AKT/GSK3β/β-catenin pathway. J Mol Histol 2021; 52(2): 1081-95.
[http://dx.doi.org/10.1007/s10735-021-10006-0]
[64]
Aminzadeh Z, Ziamajidi N, Abbasalipourkabir R. Anticancer effects of cinnamaldehyde through inhibition of ErbB2/HSF1/LDHA pathway in 5637 cell line of bladder cancer. Anticancer Agents Med Chem 2021.
[http://dx.doi.org/10.2174/1871520621666210726142814] [PMID: 34315398]
[65]
Serini S, Cassano R, Bruni M, Servidio C, Calviello G, Trombino S. Characterization of a hyaluronic acid and folic acid-based hydrogel for cisplatin delivery: Antineoplastic effect in human ovarian cancer cells in vitro. Int J Pharm 2021; 606: 120899.
[http://dx.doi.org/10.1016/j.ijpharm.2021.120899] [PMID: 34324990]
[66]
Dittmer A, Lange T, Leyh B, Dittmer J. Protein and growth-modulatory effects of carcinoma-associated fibroblasts on breast cancer cells: Role of interleukin-6. Int J Oncol 2020; 56(1): 258-72.
[PMID: 31789400]
[67]
Estruch M, Sanchez-Quesada JL, Ordoñez-Llanos J, Benitez S. Inflammatory intracellular pathways activated by electronegative LDL in monocytes. Biochim Biophys Acta 2016; 1861(9 Pt A): 963-9.
[http://dx.doi.org/10.1016/j.bbalip.2016.05.010] [PMID: 27235719]
[68]
Shilnikova K, Piao MJ, Kang KA, et al. Natural compound shikonin induces apoptosis and attenuates epithelial to mesenchymal transition in radiation-resistant human colon cancer cells. Biomol Ther (Seoul) 2021.
[http://dx.doi.org/10.4062/biomolther.2021.088] [PMID: 34321365]
[69]
Chen Y, Ni J, Gao Y, et al. Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model. Sci Rep 2020; 10(1): 14092.
[http://dx.doi.org/10.1038/s41598-020-71116-5] [PMID: 32839531]
[70]
Zhang LL, Zhan L, Jin YD, et al. SIRT2 mediated antitumor effects of shikonin on metastatic colorectal cancer. Eur J Pharmacol 2017; 797: 1-8.
[http://dx.doi.org/10.1016/j.ejphar.2017.01.008] [PMID: 28088387]
[71]
Zhang X, Cui JH, Meng QQ, Li SS, Zhou W, Xiao S. Advance in anti-tumor mechanisms of shikonin, alkannin and their derivatives. Mini Rev Med Chem 2018; 18(2): 164-72.
[http://dx.doi.org/10.2174/1389557517666170228114809] [PMID: 28245783]
[72]
Palacio-Rúa KA, Isaza-Jiménez LF, Ahumada-Rodríguez E, Muñetón-Peña CM. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer. Rev Gastroenterol Mex 2014; 79(2): 79-89.
[PMID: 24861525]
[73]
Neves SP, de Carvalho NC, da Silva MM, et al. Ruthenium complexes containing heterocyclic thioamidates trigger caspase-mediated apoptosis through MAPK signaling in human hepatocellular carcinoma cells. Front Oncol 2019; 9: 562.
[http://dx.doi.org/10.3389/fonc.2019.00562] [PMID: 31338323]
[74]
Zhang Y, Zhang H, Wu S. LncRNA-CCDC144NL-AS1 promotes the development of hepatocellular carcinoma by inducing WDR5 expression via sponging miR-940. J Hepatocell Carcinoma 2021; 8: 333-48.
[http://dx.doi.org/10.2147/JHC.S306484] [PMID: 33977095]
[75]
Slattery ML, Mullany LE, Sakoda LC, et al. The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer. Mol Carcinog 2018; 57(2): 243-61.
[http://dx.doi.org/10.1002/mc.22752] [PMID: 29068474]
[76]
Liu L, Yan J, Cao Y, et al. Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways. Oncol Lett 2021; 21(1): 70.
[http://dx.doi.org/10.3892/ol.2020.12331] [PMID: 33365081]

Rights & Permissions Print Cite
Article Metrics
40
1
© 2024 Bentham Science Publishers | Privacy Policy